← Back to Clinical Trials
RecruitingNCT06550869

Application of Anterior Quadratus Lumborum Block at the Lateral Supra-arcuate Ligament Under Laparoscopic Direct Vision in Laparoscopic Renal Surgery

◆ AI Clinical Summary
Plain-language summary for patients

Trial Parameters

ConditionPostoperative Pain
SponsorSecond Affiliated Hospital, School of Medicine, Zhejiang University
Study TypeINTERVENTIONAL
PhaseN/A
Enrollment66
SexALL
Min Age18 Years
Max Age80 Years
Start Date2024-08-14
Completion2025-08
Interventions
Anterior Quadratus Lumborum Block at the lateral supra-arcuate ligament under laparoscopic direct visionLocal infiltration anesthesia

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

Brief Summary

Evaluation of the effectiveness of Anterior Quadratus Lumborum Block at the lateral supra-arcuate ligament under laparoscopic direct vision compared to local infiltration anesthesia for postoperative analgesia after laparoscopic renal surgery in patients.A randomized controlled trial involving 66 patients undergoing laparoscopic renal surgery will assign them randomly to an experimental group or a control group.The patients in experimental group will receive Anterior Quadratus Lumborum Block at the lateral supra-arcuate ligament under laparoscopic direct vision.The patients in control group will receive local infiltration anesthesia.The primary outcome measure is the cumulative consumption of intravenous morphine equivalents at postoperative 24 hours.The secondary outcomes include the cumulative consumption of intravenous morphine equivalents at postoperative 2, 4, 6, 12 and 48 hours, Numeric Rating Scale(NRS) score at rest and during activity (coughing) at postoperative 2, 6, 24 and 48 hours, Global Comfort Questionnaire(GCQ) Comfort Status Scale Score, Quality of Recovery-15(QoR-15) Postoperative Recovery Scale Score, time of the first press on the Patient-Controlled Analgesia pump, nausea, vomiting, skin itching, drowsiness, or other adverse reactions, regional anesthesia-related complications such as local anesthetic toxicity and length of postoperative hospital stay after surgery.

Eligibility Criteria

Inclusion Criteria: * Age: 18 to 80 years old; * American Society of Anesthesiologists (ASA) physical status classification: I to III; * Undergoing laparoscopic nephrectomy or partial nephrectomy (including robotic-assisted laparoscopic nephrectomy and partial nephrectomy). Exclusion Criteria: * Recent use of anticoagulant medications or abnormal coagulation function; * Local infection at the puncture site or the presence of tumors, severe deformities, or systemic infection; * Severe renal failure (serum creatinine \> 442 μmol/L or requiring renal replacement therapy) or liver dysfunction (Child-Pugh Class C); * Known allergy to local anesthetics or a family history of local anesthetic allergy; * Preoperative cognitive impairment or inability to assess pain; * Alcoholism, drug abuse, chronic opioid dependence, or the use of analgesics or psychotropic medications for more than 3 months; * History of central and/or peripheral nervous system disorders or myasthenia gravis; * Planned admis

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology